Jun/iStock via Getty Images Preamble Since my previous article on STAAR Surgical (NASDAQ: STAA ) published on 28 November 2022, the stock price has risen 34.6% from $58.93 to a high of $79.34 on 2 Feb 2023 but not before it first cratered 20% to $46.82 on 28 December 2022. And from that February high of $79.34 it crashed again, this time by 30% to $55.39 on 28 February 2023. Two reasons led me to invest in STAA in the first place – the quality of the leadership and the fundamentals of the company. In my previous article, I focused on CEO Caren Mason who led the transformational change at STAA that improved the business fundamentals and brought it to new heights. Then, there was a CEO change in December 2022. I know little about the new CEO Mr. Thomas Frinzi, other than he was appointed to STAAR’s Board of Directors in June 2020 and had experience in the ophthalmic and medical device industries at both large, well-established companies and innovative start-ups. Prior to joining STAA, he served as Worldwide President, Surgical for Johnson & Johnson’s ( JNJ ) Vision business, and previously served as Senior Vice President of […]
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
